Antiviral Drugs Market Poised for Growth with Impressive CAGR until 2030, Driven by Rising Disease Prevalence and Treatment Advances
01. November 2024 10:02 ET
|
Research and Markets
Dublin, Nov. 01, 2024 (GLOBE NEWSWIRE) -- The "Antiviral Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. ...
Oral Antiviral Market Research 2024-2025 & 2030: A Global $37.3 Billion Market in 2023, Fueled by Advancements in Antiviral Drug Development, and Rising Demand for Effective Oral Treatments
24. Oktober 2024 10:31 ET
|
Research and Markets
Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Oral Antiviral Market 2024 Edition: Market Size, Trends, Opportunities and Forecast by Drug Class, Indication, Distribution Channel, Region, By...
$6.6 Bn Herpes Simplex Virus Infections Markets - Global Strategic Business Report to 2030 with Coverage of 10+ Major Players Including Admedus, Agenus, and Aicuris Anti-infective Cures
19. Juli 2024 08:50 ET
|
Research and Markets
Dublin, July 19, 2024 (GLOBE NEWSWIRE) -- The "Herpes Simplex Virus Infections - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
World Smallpox Treatment Market Report 2023-2030: Antiviral Drugs, Vaccination, Supportive Care Size, Share, Outlook, and Opportunity Analysis
02. Oktober 2023 04:50 ET
|
Research and Markets
Dublin, Oct. 02, 2023 (GLOBE NEWSWIRE) -- The "Smallpox Treatment Market, By Treatment Type, By Product Type, By Distribution Channel, By End User, And By Region - Size, Share, Outlook, and...
Rise in Viral Infections Drives Growth in the Oral Antiviral Market: 2021-2031 Forecast
21. September 2023 06:59 ET
|
Research and Markets
Dublin, Sept. 21, 2023 (GLOBE NEWSWIRE) -- ResearchAndMarkets.com announces a comprehensive analysis of the Oral Antiviral Market, projecting a promising CAGR of 2.1% from 2022 to 2031. The "Oral...
Defending against Viral Threats: Global Antiviral Drugs Market to Reach $74.75 Billion by 2028
04. September 2023 09:36 ET
|
Research and Markets
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Global Antiviral Drugs Market (2023-2028) by Drug Type, Disease, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" report...
Defending against Viral Threats: Global Antiviral Drugs Market to Reach $74.75 Billion by 2028
04. September 2023 09:34 ET
|
Research and Markets
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Global Antiviral Drugs Market (2023-2028) by Drug Type, Disease, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" report...
Molnupiravir Global Market Report 2023: Rising Instances of COVID-19 Drives Growth
08. März 2023 05:03 ET
|
Research and Markets
Dublin, March 08, 2023 (GLOBE NEWSWIRE) -- The "Molnupiravir Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Application (Influenza, Ebola, COVID-19,...
Antivirals Global Market Report 2023: A $156.99 Billion Market by 2027 - Long-term Forecast to 2032 Featuring AbbVie, Bristol-Myers-Squibb, Cipla, F. Hoffmann-La Roche, & Gilead Sciences
22. Februar 2023 08:03 ET
|
Research and Markets
Dublin, Feb. 22, 2023 (GLOBE NEWSWIRE) -- The "Antivirals Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global antivirals market will grow from $97.14...
Nature Reviews Drug Discovery Article Offers Independent Support for ProLectin-I in Fibrosis and ProLectin-M as an Antiviral Drug
22. Februar 2023 08:00 ET
|
BIOXYTRAN, INC.
BOSTON, MASSACHUSETTS, Feb. 22, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat...